Your browser doesn't support javascript.
loading
Improving outcomes for high-risk DLBCL: a pilot study looking at the role of fractionated cyclophosphamide with RCHOP chemo-immunotherapy (SCUBA-1 trial).
Singh, Charanpreet; Malhotra, Pankaj; Jandial, Aditya; Jain, Arihant; Lad, Deepesh; Khadwal, Alka; Bal, Amanjit; Das, Ashim; Mittal, B R; Prakash, Gaurav.
Afiliación
  • Singh C; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Malhotra P; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Jandial A; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Jain A; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Lad D; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Khadwal A; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Bal A; Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Das A; Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Mittal BR; Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Prakash G; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Indian J Hematol Blood Transfus ; 39(1): 77-84, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36091934
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Indian J Hematol Blood Transfus Año: 2023 Tipo del documento: Article País de afiliación: India
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Indian J Hematol Blood Transfus Año: 2023 Tipo del documento: Article País de afiliación: India